M&As this week: MedSphere Shanghai, Zeltiq Aesthetics, Hologic

16 February 2017 (Last Updated February 16th, 2017 18:30)

Forerunner Medical has completed the acquisition of MedSphere Shanghai, a subsidiary of MedSphere International. Both companies manufacture minimally-invasive medical devices.

Forerunner Medical has completed the acquisition of MedSphere Shanghai, a subsidiary of MedSphere International. Both companies manufacture minimally-invasive medical devices.

Medical technology company, Zeltiq Aesthetics, will be sold to Allergan for a purchase consideration of up to $2.475bn.

As per the definitive agreement signed between the two companies, Zeltiq Aesthetics’ flagship product, CoolSculpting System, will be added to Allergan’s global portfolio of medical aesthetics, following the acquisition.

"Zeltiq Aesthetics’ flagship product, CoolSculpting System, will be added to Allergan’s global portfolio of medical aesthetics, following the acquisition."

CoolSculpting System is an FDA-cleared product, which reduces unwanted fat using a patented cooling technology.

Diagnostic products provider, Hologic, has signed a definitive agreement to buy the entire outstanding shares of aesthetic treatment systems provider, Cynosure, for $66 a share, which corresponds to an equity value of approximately $1.65bn and an enterprise value of $1.44bn, in cash.

Cynosure will merge to become a wholly-owned subsidiary of Hologic, upon completion of the transaction.

In a move to further expand its position in structural biology, Anatrace, a distributor of detergents and lipids, has acquired Molecular Dimensions.

The target company has clients operating in structural biology research across Europe, the Americas and Asia focused on drug discovery.